Renal pathology in the pediatric transplant patient

Advances in Anatomic Pathology

Volumn 14, Issue 3, 2007, Pages 202-216

  Vogler, Carole ^a,c   Wang, Yihan ^b   Brink, David S ^a   Wood, Ellen ^a   Belsha, Craig ^a   Walker, Patrick D ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nephropathology Associates   (United States)

^c Cardinal Glennon Hospital   (United States)

Author keywords

Kidney biopsy; Pediatric transplantation; Renal allograft; Renal transplant; Transplant rejection

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

CHILD; CLINICAL FEATURE; EPSTEIN BARR VIRUS; GLOMERULONEPHRITIS; GRAFT INFECTION; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; NEPHROTOXICITY; POINT OF CARE TESTING; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; REVIEW;

CHILD; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION;

EID: 34247467883     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3180504927     Document Type: Review

References (86)

1. Smith JM, McDonald RA. Renal transplantation in adolescents. Adolesc Med Clin. 2005;16:201-214.
2. Marsden PA. Predicting outcomes after renal transplantation - new tools and old tools. N Engl J Med. 2003;349:182-184.
3. Neu AM. Special issues in pediatric kidney transplantation. Adv Chronic Kidney Dis. 2006;13:62-69.
4. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931-940.
5. D'Agati VD, Jennette JC, Silva FG. Pathology of renal transplantation. In: Donald WK, ed. Non-Neoplastic Kidney Diseases. Washington, DC: American Registry of Pathology/Armed Forces Institute of Pathology; 2005:667-709.
6. Durkan AM, Beattie TJ, Howatson A, et al. Renal transplant biopsy specimen adequacy in a paediatric population. Pediatr Nephrol. 2006;21:265-269.
7. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713-723.
8. Colvin RB. The renal allograft biopsy. Kidney Int. 1996;50:1069-1082.
9. Herrera GA, Isaac J, Turbat-Herrera EA. Role of electron microscopy in transplant renal pathology. Ultrastruct Pathol. 1997;21:481-498.
10. Ivanyi B, Kemeny E, Szederkenyi E, et al. The value of electron microscopy in the diagnosis of chronic renal allograft rejection. Mod Pathol. 2001;14:1200-1208.
11. Collan Y, Hirsimaki P, Aho H, et al. Value of electron microscopy in kidney biopsy diagnosis. Ultrastruct Pathol. 2005;29:461-468.
12. Benfield MR, Herrin J, Feld L, et al. Safety of kidney biopsy in pediatric transplantation: a report of the controlled clinical trials in pediatric Transplantation Trial of Induction Therapy Study Group. Transplantation. 1999;67:544-547.
13. Vidhun J, Masciandro J, Varich L, et al. Safety and risk stratification of percutaneous biopsies of adult-sized renal allografts in infant and older pediatric recipients. Transplantation. 2003;76:552-557.
14. Matas AJ, Solez K. From first principles - tubulitis in protocol biopsies and learning from history. Am J Transplant. 2001;1:4-5.
15. Seikku P, Krogerus L, Jalanko H, et al. Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children. Pediatr Transplant. 2005;9:754-762.
16. Birk PE, Stannard KM, Konrad HB, et al. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant. 2004;8:29-38.
17. Shapiro R, Starzl TE. Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant. 2006;10:766-767.
18. Tejani AH, Stablein DM, Sullivan EK, et al. The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant. 1998;2:318-324.
19. Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol. 2002;13:242-251.
20. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant. 2003;3:708-714.
21. Ordonez NG, Rosai J. Urinary Tract: Kidney, renal pelvis, and ureter, bladder. In: Rosai J, ed. Rosai and Ackerman's Surgical Pathology. Edinburgh: Mosby; 2004:1219-1224.
22. Colvin RB, Cohen AH, Saiontz C, et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol. 1997;8:1930-1941.
23. Corey HE, Greenstein SM, Tellis V, et al. Renal allograft rejection in children and young adults: the Banff classification. Pediatr Nephrol. 1995;9:309-312.
24. Schweitzer EJ, Drachenberg CB, Anderson L, et al. Significance of the Banff borderline biopsy. Am J Kidney Dis. 1996;28:585-588.
25. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349:125-138.
26. Desvaux D, Le Gouvello S, Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant. 2004;19:933-939.
27. Magil AB. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis. 2005;45:1084-1089.
28. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens. 2002;11:609-618.
29. Magil AB, Tinckam KJ. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant. 2006;21:1382-1388.
30. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002;13:779-787.
31. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int. 2005;68:1866-1874.
32. Cascalho M, Platt JL. Basic mechanisms of humoral rejection. Pediatr Transplant. 2005;9:9-16.
33. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999;10:2208-2214.
34. Herman J, Lerut E, Van Damme-Lombaerts R, et al. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation. 2005;79:1435-1440.
35. Mengel M, Bogers J, Bosmans JL, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant. 2005;5:1050-1056.
36. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant. 2003;18:2232-2239.
37. Vargha R, Mueller T, Arbeiter K, et al. C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejection. Pediatr Transplant. 2006;10:449-453.
38. Gloor JM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation. 2003;75:971-977.
39. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant. 2006;6:1829-1840.
40. Tonshoff B, Hocker B. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant. 2006;10:721-729.
41. Tejani A, Ho PL, Emmett L, et al. Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Transplant. 2002;2:142-147.
42. Pape L, Henne T, Offner G, et al. Computer-assisted quantification of fibrosis in chronic allograft nephropathy by picrosirius red-staining: a new tool for predicting long-term graft function. Transplantation. 2003;76:955-958.
43. Grimm P. The protocol renal allograft biopsy: has its time come? Pediatr Transplant. 2004;8:3-5.
44. Kerby JD, Verran DJ, Luo KL, et al. Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection. Transplantation. 1996;62:190-200.
45. Sharma VK, Bologa RM, Xu GP, et al. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int. 1996;49:1297-1303.
46. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005;5:807-817.
47. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation. 1998;66:1736-1740.
48. Gough J, Yilmaz A, Miskulin D, et al. Peritubular capillary basement membrane reduplication in allografts and native kidney disease: a clinicopathologic study of 278 consecutive renal specimens. Transplantation. 2001;71:1390-1393.
49. Alonso EM. Long-term renal function in pediatric liver and heart recipients. Pediatr Transplant. 2004;8:381-385.
50. Nankivell BJ, Borrows RJ, Fung CL, et al. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004;78:557-565.
51. Kamimaki I, Shishido S, Ikeda M, et al. Histopathological findings of 10-year protocol biopsy in pediatric kidney transplant recipients. Transplant Proc. 2002;34:3130-3131.
52. Morozumi K, Takeda A, Uchida K, et al. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Transplant Proc. 2004;36:251S-256S.
53. Meehan SM, Pascual M, Williams WW, et al. De novo collapsing glomerulopathy in renal allografts. Transplantation. 1998;65:1192-1197.
54. Nadasdy T, Allen C, Zand MS. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes. Hum Pathol. 2002;33:437-441.
55. Stokes MB, Davis CL, Alpers CE. Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis. 1999;33:658-666.
56. Smith JM, McDonald RA, Finn LS, et al. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant. 2004;4:2109-2117.
57. Herman J, Van RM, Snoeck R, et al. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transplant. 2004;8:485-492.
58. Nickeleit V, Singh HK, Mihatsch MJ. Latent and productive polyomavirus infections of renal allografts: morphological, clinical and pathophysiological aspects. In: Ahsan N, ed. Polyomaviruses and Human Diseases. New York: Springer Science Business Media; 2006:190-200.
59. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79:1277-1286.
60. Singh HK, Bubendorf L, Mihatsch MJ, et al. Urine cytology findings of polyomavirus infections. In: Ahsan N, ed. Polyomaviruses and Human Diseases. New York: Springer Science Business Media; 2006:201-212.
61. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int. 2006;69:655-662.
62. Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol. 2004;42:1176-1180.
63. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant. 2000;15:324-332.
64. Herrera GA, Veeramachaneni R, Turbat-Herrera EA. Electron microscopy in the diagnosis of BK-polyoma virus infection in the transplanted kidney. Ultrastruct Pathol. 2005;29:469-474.
65. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation. 2006;81:643-654.
66. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5:582-594.
67. Hoffman JA. Adenoviral disease in pediatric solid organ transplant recipients. Pediatr Transplant. 2006;10:17-25.
68. Holmes RD, Sokol RJ. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant. 2002;6:456-464.
69. Kopf S, Tonshoff B. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients. Pediatr Nephrol. 2004;19:365-368.
70. Shroff R, Rees L. The post-transplant lymphoproliferative disorder- a literature review. Pediatr Nephrol. 2004;19:369-377.
71. Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999;68:1851-1854.
72. Dharnidharka VR, Sullivan EK, Stablein DM, et al. Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001;71:1065-1068.
73. Harmon WE. Pediatric renal transplantation. In: Avner ED, Harmon WE, Niaudet P, eds. Pediatric Nephrology. Philadelphia: Lippincott Williams & Wilkins; 2003:1437-1468.
74. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol. 1997;14:8-14.
75. Pinkerton CR, Hann I, Weston CL, et al. Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry. Br J Haematol. 2002;118:456-461.
76. Cameron JS. Recurrent primary disease and de novo nephritis following renal transplantation. In: Tejani AH, Fine RN, eds. Pediatric Renal Transplantation. New York: Wiley-Liss; 1994:503-523.
77. Baqi N, Tejani A. Recurrence of the original disease in pediatric renal transplantation. J Nephrol. 1997;10:85-92.
78. Weber S, Tonshoff B. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects. Transplantation. 2005;80:S128-S134.
79. Seikaly MG. Recurrence of primary disease in children after renal transplantation: an evidence-based update. Pediatr Transplant. 2004;8:113-119.
80. Hubsch H, Montane B, Abitbol C, et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr Nephrol. 2005;20:210-216.
81. Nathanson S, Cochat P, Andre JL, et al. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression. Pediatr Nephrol. 2005;20:1801-1804.
82. Baum MA, Ho M, Stablein D, et al. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr Transplant. 2002;6:488-492.
83. Quan A, Sullivan EK, Alexander SR. Recurrence of hemolytic uremic syndrome after renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation. 2001;72:742-745.
84. Olie KH, Florquin S, Groothoff JW, et al. Atypical relapse of hemolytic uremic syndrome after transplantation. Pediatr Nephrol. 2004;19:1173-1176.
85. Bunchman TE, So SKS. Diagnosis and treatment of postoperative allograft dysfunction. In: Tejani AH, Fine RN, eds. Pediatric Renal Transplantation. New York: Wiley-Liss; 1994:257-268.
86. Sebire NJ, Bockenhauer D. Posttransplant de novo membranous nephropathy in childhood. Fetal Pediatr Pathol. 2005;24:95-103.